Michael L Kendrick1, Daniel Cusati. 1. Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. kendrick.michael@mayo.edu
Abstract
HYPOTHESIS: Total laparoscopic pancreaticoduodenectomy is a safe and effective therapeutic approach. DESIGN: Single-institutional retrospective review. SETTING: Tertiary referral center. PATIENTS: All consecutive patients undergoing total laparoscopic pancreaticoduodenectomy from July 2007 through July 2009 at a single center (n = 62). MAIN OUTCOME MEASURES: Blood loss, operative time, postoperative morbidity, length of hospital stay, and 30-day or in-hospital mortality. RESULTS: Of 65 patients undergoing laparoscopic resection, 62 patients with a mean age of 66 years (SD, 12 years) underwent total laparoscopic pancreaticoduodenectomy. The pancreaticojejunostomy consisted of a duct-to-mucosa anastomosis with interrupted suture. Median operative time was 368 minutes (range, 258-608 minutes) and median blood loss was 240 mL (range, 30-1200 mL). Diagnosis was pancreatic adenocarcinoma (n = 31), intraductal papillary mucinous neoplasm (n = 12), periampullary adenocarcinoma (n = 8), neuroendocrine tumor (n = 4), chronic pancreatitis (n = 3), cholangiocarcinoma (n = 1), metastatic renal cell carcinoma (n = 1), cystadenoma (n = 1), and duodenal adenoma (n = 1). Median tumor size was 3 cm (range, 0.9-10.0 cm) and the median number of lymph nodes harvested was 15 (range, 6-31). Perioperative morbidity occurred in 26 patients and included pancreatic fistula (n = 11), delayed gastric emptying (n = 9), bleeding (n = 5), and deep vein thrombosis (n = 2). There was 1 postoperative mortality. Median length of hospital stay was 7 days (range, 4-69 days). CONCLUSIONS: Laparoscopic pancreaticoduodenectomy is feasible, safe, and effective. Outcomes appear comparable with those via the open approach; however, controlled trials are needed. Despite this series representing experience within the learning curve, laparoscopic pancreaticoduodenectomy holds promise for providing advantages seen with minimally invasive approaches in other procedures.
HYPOTHESIS: Total laparoscopic pancreaticoduodenectomy is a safe and effective therapeutic approach. DESIGN: Single-institutional retrospective review. SETTING: Tertiary referral center. PATIENTS: All consecutive patients undergoing total laparoscopic pancreaticoduodenectomy from July 2007 through July 2009 at a single center (n = 62). MAIN OUTCOME MEASURES: Blood loss, operative time, postoperative morbidity, length of hospital stay, and 30-day or in-hospital mortality. RESULTS: Of 65 patients undergoing laparoscopic resection, 62 patients with a mean age of 66 years (SD, 12 years) underwent total laparoscopic pancreaticoduodenectomy. The pancreaticojejunostomy consisted of a duct-to-mucosa anastomosis with interrupted suture. Median operative time was 368 minutes (range, 258-608 minutes) and median blood loss was 240 mL (range, 30-1200 mL). Diagnosis was pancreatic adenocarcinoma (n = 31), intraductal papillary mucinous neoplasm (n = 12), periampullary adenocarcinoma (n = 8), neuroendocrine tumor (n = 4), chronic pancreatitis (n = 3), cholangiocarcinoma (n = 1), metastatic renal cell carcinoma (n = 1), cystadenoma (n = 1), and duodenal adenoma (n = 1). Median tumor size was 3 cm (range, 0.9-10.0 cm) and the median number of lymph nodes harvested was 15 (range, 6-31). Perioperative morbidity occurred in 26 patients and included pancreatic fistula (n = 11), delayed gastric emptying (n = 9), bleeding (n = 5), and deep vein thrombosis (n = 2). There was 1 postoperative mortality. Median length of hospital stay was 7 days (range, 4-69 days). CONCLUSIONS: Laparoscopic pancreaticoduodenectomy is feasible, safe, and effective. Outcomes appear comparable with those via the open approach; however, controlled trials are needed. Despite this series representing experience within the learning curve, laparoscopic pancreaticoduodenectomy holds promise for providing advantages seen with minimally invasive approaches in other procedures.
Authors: Tobias Keck; Simon Küsters; Ulrich Friedrich Wellner; Ulrich Theodor Hopt; Konrad Wojciech Karcz Journal: Langenbecks Arch Surg Date: 2012-05-31 Impact factor: 3.445
Authors: John A Stauffer; Cameron D Adkisson; Douglas L Riegert-Johnson; Ross F Goldberg; Steven P Bowers; Horacio J Asbun Journal: World J Surg Date: 2012-10 Impact factor: 3.352
Authors: Carlos Fernández-del Castillo; Vicente Morales-Oyarvide; Deborah McGrath; Jennifer A Wargo; Cristina R Ferrone; Sarah P Thayer; Keith D Lillemoe; Andrew L Warshaw Journal: Surgery Date: 2012-07-06 Impact factor: 3.982
Authors: Erin H Baker; Samuel W Ross; Ramanathan Seshadri; Ryan Z Swan; David A Iannitti; Dionisios Vrochides; John B Martinie Journal: J Gastrointest Oncol Date: 2015-08
Authors: May C Tee; Kristopher P Croome; Christopher R Shubert; Michael B Farnell; Mark J Truty; Florencia G Que; K Marie Reid-Lombardo; Rory L Smoot; David M Nagorney; Michael L Kendrick Journal: HPB (Oxford) Date: 2015-08-20 Impact factor: 3.647
Authors: Thijs de Rooij; Sjors Klompmaker; Mohammad Abu Hilal; Michael L Kendrick; Olivier R Busch; Marc G Besselink Journal: Nat Rev Gastroenterol Hepatol Date: 2016-02-17 Impact factor: 46.802